Kyverna Therapeutics is a cell therapy company based in Emeryville, CA, specializing in the development of innovative treatments for autoimmune and inflammatory diseases. Their cutting-edge therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to target and eliminate autoreactive immune cells responsible for these conditions.
With a focus on B cell-driven autoimmune diseases, Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR-T) therapies in both autologous and allogeneic formats. By leveraging their expertise in cell engineering, Kyverna aims to revolutionize the field of cell therapy and provide effective solutions for patients suffering from autoimmune and inflammatory disorders.
Generated from the website